1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: August 23-29, 2026
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: August 23-29, 2026

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Kyle Diamantas, J.D., Acting Commissioner of Food and Drugs

Event Date: 08/24/2026
Location: Washington, DC 
Subject: School Meals and Grocer Roundtable 
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, government, and other stakeholders

Official Name: Sean R. Keveney, J.D., Chief Counsel

Event Date: 08/25/2026
Location: Washington, DC 
Subject: Annexon
FDA Participant/Group: N/A
Non FDA Participant/Group: Deeona Gaskin, Dino LaVerghetta (Sidley Austin);

Event Date: 08/27/2026
Location: Washington, DC
Subject: React Health Inc. / BMC Medical 510(k)
FDA Participant/Group: N/A
Non FDA Participant/Group: Bill Holtz, John Strom (Foley Hoag);

Event Date: 08/27/2026
Location: Silver Spring, MD
Subject: Sydnexis
FDA Participant/Group: N/A
Non FDA Participant/Group: David Fox (Hogan Lovells); Deborah Livornese (Hyman, Phelps & McNamara);

Official Name: Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs

Event Date: 08/28/2026
Location: Virtual
Subject: Research on Benchmark for Patient-Facing AI Care
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Amazon representatives

Official Name: Lowell Zeta, J.D., Deputy Commissioner for Strategic Initiatives

Event Date: 08/27/2026
Location: Virtual
Subject: Nanoscope Pending Filing Decision
FDA Participant/Group: KARIM MIKHAIL; 
Non FDA Participant/Group: Samarendra Monhanty, Samuel Barone, Sulagna Bhattacharya (Nanoscope Therapeutics); Frank J. Sasinowski, James E. Valentine (Hyman, Phelps & McNamara, P.C.);

Event Date: 08/28/2026
Location: Virtual
Subject: Proprietary Name Unacceptable Letter
FDA Participant/Group: LUKE HALL; KARIM MIKHAIL; 
Non FDA Participant/Group: Matt Wilsey (Grace Science LLC);

Official Name: Donald A. Prater, D.V.M., Acting Deputy Commissioner for Food

Event Date: 08/27/2026
Location: College Park, MD
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Safe Food Coalition representatives

Official Name: Melanie Keller, M.B.A., Deputy Commissioner for Operations and Chief Operating Officer

No Significant Event

Official Name: Elizabeth Miller, Pharm.D., Associate Commissioner for Inspections and Investigations

No Significant Event

Official Name: Karim Mikhail, B.Pharm, MSc, Acting Director, Center for Biologics Evaluation and Research

Event Date: 08/25/2026
Location: Virtual
Subject: Vaccine Data Coverage Follow Up
FDA Participant/Group: DAVID KASLOW; 
Non FDA Participant/Group: Nandini Selvam, Rachel Fones, Rosenie Thelus, Silvia Valkova (IQVIA);

Event Date: 08/27/2026
Location: Virtual
Subject: Xenotransplantation
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Jay Barth (eGenesis Inc.);

Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health

Event Date: 08/24/2026
Location: Silver Spring, MD
Subject: General Medical Device Updates
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Harrison AI representatives

Official Name: Michael Davis, M.D., Ph.D., Acting Director, Center for Drug Evaluation and Research

Event Date: 08/24/2026
Location: Silver Spring, MD
Subject: Modernizing Pulmonary Drug Development to Accelerate Safe Patient Access
FDA Participant/Group: AMY RICK; LISA YANOFF; SARAH IBRAHIM; 
Non FDA Participant/Group: Max Bronstein (Aviva Strategies);

Event Date: 08/25/2026
Location: Silver Spring, MD
Subject: Tanruprubart
FDA Participant/Group: TERESA BURACCHIO; LAURA JAWIDZIK; JAMIE RAULERSON; AMY RICK; 
Non FDA Participant/Group: Deeona Gaskin, Dino L. Laverghetta (Sidley Austin);

Event Date: 08/25/2026
Location: Silver Spring, MD
Subject: Clinical Trial Modernization Efforts
FDA Participant/Group: DIANNE PARAOAN; 
Non FDA Participant/Group: Janice Chang (Transcelerate BioPharma);

Official Name: Bret Koplow, Ph.D., J.D., Acting Director, Center for Tobacco Products

No Significant Event

Official Name: Timothy C. Schell, Ph.D., Director, Center for Veterinary Medicine

No Significant Event

Back to Top